swiss-pdb viewer (aka deepview) (SIB Swiss Institute of Bioinformatics)
90
Structured Review
SIB Swiss Institute of Bioinformatics
swiss-pdb viewer (aka deepview)
Swiss Pdb Viewer (Aka Deepview), supplied by SIB Swiss Institute of Bioinformatics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pymol+software+(python-based+molecular+visualization+system)/swiss+pdbviewer4+1+software/pm37269287-1086-2-14
Average 90 stars, based on 1 article reviews
Swiss Pdb Viewer (Aka Deepview), supplied by SIB Swiss Institute of Bioinformatics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pymol+software+(python-based+molecular+visualization+system)/swiss+pdbviewer4+1+software/pm37269287-1086-2-14
Average 90 stars, based on 1 article reviews
swiss-pdb viewer (aka deepview) - by Bioz Stars,
2026-11
90/100 stars
Images
Related Articles
Microscopy:Article Title: Hexameric tetrahedral RNA nanostructures Article Snippet: A Article Title: The intrinsically disordered region of coronins fine-tunes oligomerization and actin polymerization. Article Snippet: REAGENT or Article Title: The β-chain mutation p.Trp433Stop impairs fibrinogen secretion: A novel nonsense mutation associated with hypofibrinogenemia. Article Snippet: Fibrinogen, a hexameric glycoprotein composed of Aα, Bβ, and γ chains, is the most abundant clotting factor in human circulation, and it has a multitude of functions, including platelet aggregation, primary and secondary hemostasis, and fibrinolysis.1 Congenital fibrinogen disorders are divided into two categories: type I, consisting of quantitative defects (afibrinogenemia or hypofibrinogenemia) characterized by absent or low plasma fibrinogen antigen and activity levels, and type II, consisting of qualitative defects Received: 8 December 2020 | Revised: 12 May 2021 | Accepted: 27 May 2021 DOI: 10.1111/ijlh.13632 Article Title: Protocol to identify multiple protein targets and therapeutic compounds using an in silico polypharmacological approach Article Snippet: Article Title: Hexameric tetrahedral RNA nanostructures Article Snippet: A three-dimensional Article Title: Ubiquitin Modification by the E3 Ligase/ADP-ribosyltransferase Dtx3L/Parp9 Article Snippet: Article Title: A novel fibrinogen gamma-chain mutation, p.Cys165Arg, causes disruption of the γ165Cys-Bβ227Cys disulfide bond and ultimately leads to hypofibrinogenemia. Article Snippet: Background: Congenital hypofibrinogenemia is a type of hereditary disease characterized by impaired fibrinogen synthesis and/or secretion induced by mutations in the fibrinogen gene.. Objectives: We investigated the phenotypes, genotypes, and pathogenesis of congenital hypofibrinogenemia in Article Title: Genetic analysis of a pedigree with hereditary coagulation factor XI deficiency Article Snippet: To identify potential mutations of F11 gene in a family with hereditary coagulation factor XI (FXI) deficiency and explore the molecular pathogenesis.. The FXI activity and FXI antigen were tested with clotting assay and ELISA, respectively.. The FXI gene was amplified by PCR with direct sequencing. Electron Microscopy:Article Title: Hexameric tetrahedral RNA nanostructures Article Snippet: A Article Title: The intrinsically disordered region of coronins fine-tunes oligomerization and actin polymerization. Article Snippet: REAGENT or Article Title: The β-chain mutation p.Trp433Stop impairs fibrinogen secretion: A novel nonsense mutation associated with hypofibrinogenemia. Article Snippet: Fibrinogen, a hexameric glycoprotein composed of Aα, Bβ, and γ chains, is the most abundant clotting factor in human circulation, and it has a multitude of functions, including platelet aggregation, primary and secondary hemostasis, and fibrinolysis.1 Congenital fibrinogen disorders are divided into two categories: type I, consisting of quantitative defects (afibrinogenemia or hypofibrinogenemia) characterized by absent or low plasma fibrinogen antigen and activity levels, and type II, consisting of qualitative defects Received: 8 December 2020 | Revised: 12 May 2021 | Accepted: 27 May 2021 DOI: 10.1111/ijlh.13632 Article Title: Protocol to identify multiple protein targets and therapeutic compounds using an in silico polypharmacological approach Article Snippet: Article Title: Hexameric tetrahedral RNA nanostructures Article Snippet: A three-dimensional Article Title: Ubiquitin Modification by the E3 Ligase/ADP-ribosyltransferase Dtx3L/Parp9 Article Snippet: Article Title: A novel fibrinogen gamma-chain mutation, p.Cys165Arg, causes disruption of the γ165Cys-Bβ227Cys disulfide bond and ultimately leads to hypofibrinogenemia. Article Snippet: Background: Congenital hypofibrinogenemia is a type of hereditary disease characterized by impaired fibrinogen synthesis and/or secretion induced by mutations in the fibrinogen gene.. Objectives: We investigated the phenotypes, genotypes, and pathogenesis of congenital hypofibrinogenemia in Article Title: Genetic analysis of a pedigree with hereditary coagulation factor XI deficiency Article Snippet: To identify potential mutations of F11 gene in a family with hereditary coagulation factor XI (FXI) deficiency and explore the molecular pathogenesis.. The FXI activity and FXI antigen were tested with clotting assay and ELISA, respectively.. The FXI gene was amplified by PCR with direct sequencing. Software:Article Title: Hexameric tetrahedral RNA nanostructures Article Snippet: A Article Title: The intrinsically disordered region of coronins fine-tunes oligomerization and actin polymerization. Article Snippet: REAGENT or Article Title: The β-chain mutation p.Trp433Stop impairs fibrinogen secretion: A novel nonsense mutation associated with hypofibrinogenemia. Article Snippet: Fibrinogen, a hexameric glycoprotein composed of Aα, Bβ, and γ chains, is the most abundant clotting factor in human circulation, and it has a multitude of functions, including platelet aggregation, primary and secondary hemostasis, and fibrinolysis.1 Congenital fibrinogen disorders are divided into two categories: type I, consisting of quantitative defects (afibrinogenemia or hypofibrinogenemia) characterized by absent or low plasma fibrinogen antigen and activity levels, and type II, consisting of qualitative defects Received: 8 December 2020 | Revised: 12 May 2021 | Accepted: 27 May 2021 DOI: 10.1111/ijlh.13632 Article Title: Protocol to identify multiple protein targets and therapeutic compounds using an in silico polypharmacological approach Article Snippet: Article Title: Hexameric tetrahedral RNA nanostructures Article Snippet: A three-dimensional Article Title: Ubiquitin Modification by the E3 Ligase/ADP-ribosyltransferase Dtx3L/Parp9 Article Snippet: Article Title: A novel fibrinogen gamma-chain mutation, p.Cys165Arg, causes disruption of the γ165Cys-Bβ227Cys disulfide bond and ultimately leads to hypofibrinogenemia. Article Snippet: Background: Congenital hypofibrinogenemia is a type of hereditary disease characterized by impaired fibrinogen synthesis and/or secretion induced by mutations in the fibrinogen gene.. Objectives: We investigated the phenotypes, genotypes, and pathogenesis of congenital hypofibrinogenemia in Article Title: Genetic analysis of a pedigree with hereditary coagulation factor XI deficiency Article Snippet: To identify potential mutations of F11 gene in a family with hereditary coagulation factor XI (FXI) deficiency and explore the molecular pathogenesis.. The FXI activity and FXI antigen were tested with clotting assay and ELISA, respectively.. The FXI gene was amplified by PCR with direct sequencing. Construct:Article Title: Hexameric tetrahedral RNA nanostructures Article Snippet: A Article Title: The intrinsically disordered region of coronins fine-tunes oligomerization and actin polymerization. Article Snippet: REAGENT or Article Title: The β-chain mutation p.Trp433Stop impairs fibrinogen secretion: A novel nonsense mutation associated with hypofibrinogenemia. Article Snippet: Fibrinogen, a hexameric glycoprotein composed of Aα, Bβ, and γ chains, is the most abundant clotting factor in human circulation, and it has a multitude of functions, including platelet aggregation, primary and secondary hemostasis, and fibrinolysis.1 Congenital fibrinogen disorders are divided into two categories: type I, consisting of quantitative defects (afibrinogenemia or hypofibrinogenemia) characterized by absent or low plasma fibrinogen antigen and activity levels, and type II, consisting of qualitative defects Received: 8 December 2020 | Revised: 12 May 2021 | Accepted: 27 May 2021 DOI: 10.1111/ijlh.13632 Article Title: Protocol to identify multiple protein targets and therapeutic compounds using an in silico polypharmacological approach Article Snippet: Article Title: Hexameric tetrahedral RNA nanostructures Article Snippet: A three-dimensional Article Title: Ubiquitin Modification by the E3 Ligase/ADP-ribosyltransferase Dtx3L/Parp9 Article Snippet: Article Title: A novel fibrinogen gamma-chain mutation, p.Cys165Arg, causes disruption of the γ165Cys-Bβ227Cys disulfide bond and ultimately leads to hypofibrinogenemia. Article Snippet: Background: Congenital hypofibrinogenemia is a type of hereditary disease characterized by impaired fibrinogen synthesis and/or secretion induced by mutations in the fibrinogen gene.. Objectives: We investigated the phenotypes, genotypes, and pathogenesis of congenital hypofibrinogenemia in Article Title: Genetic analysis of a pedigree with hereditary coagulation factor XI deficiency Article Snippet: To identify potential mutations of F11 gene in a family with hereditary coagulation factor XI (FXI) deficiency and explore the molecular pathogenesis.. The FXI activity and FXI antigen were tested with clotting assay and ELISA, respectively.. The FXI gene was amplified by PCR with direct sequencing. Mutagenesis:Article Title: Hexameric tetrahedral RNA nanostructures Article Snippet: A Article Title: The intrinsically disordered region of coronins fine-tunes oligomerization and actin polymerization. Article Snippet: REAGENT or Article Title: The β-chain mutation p.Trp433Stop impairs fibrinogen secretion: A novel nonsense mutation associated with hypofibrinogenemia. Article Snippet: Fibrinogen, a hexameric glycoprotein composed of Aα, Bβ, and γ chains, is the most abundant clotting factor in human circulation, and it has a multitude of functions, including platelet aggregation, primary and secondary hemostasis, and fibrinolysis.1 Congenital fibrinogen disorders are divided into two categories: type I, consisting of quantitative defects (afibrinogenemia or hypofibrinogenemia) characterized by absent or low plasma fibrinogen antigen and activity levels, and type II, consisting of qualitative defects Received: 8 December 2020 | Revised: 12 May 2021 | Accepted: 27 May 2021 DOI: 10.1111/ijlh.13632 Article Title: Protocol to identify multiple protein targets and therapeutic compounds using an in silico polypharmacological approach Article Snippet: Article Title: Hexameric tetrahedral RNA nanostructures Article Snippet: A three-dimensional Article Title: Ubiquitin Modification by the E3 Ligase/ADP-ribosyltransferase Dtx3L/Parp9 Article Snippet: Article Title: A novel fibrinogen gamma-chain mutation, p.Cys165Arg, causes disruption of the γ165Cys-Bβ227Cys disulfide bond and ultimately leads to hypofibrinogenemia. Article Snippet: Background: Congenital hypofibrinogenemia is a type of hereditary disease characterized by impaired fibrinogen synthesis and/or secretion induced by mutations in the fibrinogen gene.. Objectives: We investigated the phenotypes, genotypes, and pathogenesis of congenital hypofibrinogenemia in Article Title: Genetic analysis of a pedigree with hereditary coagulation factor XI deficiency Article Snippet: To identify potential mutations of F11 gene in a family with hereditary coagulation factor XI (FXI) deficiency and explore the molecular pathogenesis.. The FXI activity and FXI antigen were tested with clotting assay and ELISA, respectively.. The FXI gene was amplified by PCR with direct sequencing. FLAG-tag:Article Title: Hexameric tetrahedral RNA nanostructures Article Snippet: A Article Title: The intrinsically disordered region of coronins fine-tunes oligomerization and actin polymerization. Article Snippet: REAGENT or Article Title: The β-chain mutation p.Trp433Stop impairs fibrinogen secretion: A novel nonsense mutation associated with hypofibrinogenemia. Article Snippet: Fibrinogen, a hexameric glycoprotein composed of Aα, Bβ, and γ chains, is the most abundant clotting factor in human circulation, and it has a multitude of functions, including platelet aggregation, primary and secondary hemostasis, and fibrinolysis.1 Congenital fibrinogen disorders are divided into two categories: type I, consisting of quantitative defects (afibrinogenemia or hypofibrinogenemia) characterized by absent or low plasma fibrinogen antigen and activity levels, and type II, consisting of qualitative defects Received: 8 December 2020 | Revised: 12 May 2021 | Accepted: 27 May 2021 DOI: 10.1111/ijlh.13632 Article Title: Protocol to identify multiple protein targets and therapeutic compounds using an in silico polypharmacological approach Article Snippet: Article Title: Hexameric tetrahedral RNA nanostructures Article Snippet: A three-dimensional Article Title: Ubiquitin Modification by the E3 Ligase/ADP-ribosyltransferase Dtx3L/Parp9 Article Snippet: Article Title: A novel fibrinogen gamma-chain mutation, p.Cys165Arg, causes disruption of the γ165Cys-Bβ227Cys disulfide bond and ultimately leads to hypofibrinogenemia. Article Snippet: Background: Congenital hypofibrinogenemia is a type of hereditary disease characterized by impaired fibrinogen synthesis and/or secretion induced by mutations in the fibrinogen gene.. Objectives: We investigated the phenotypes, genotypes, and pathogenesis of congenital hypofibrinogenemia in Article Title: Genetic analysis of a pedigree with hereditary coagulation factor XI deficiency Article Snippet: To identify potential mutations of F11 gene in a family with hereditary coagulation factor XI (FXI) deficiency and explore the molecular pathogenesis.. The FXI activity and FXI antigen were tested with clotting assay and ELISA, respectively.. The FXI gene was amplified by PCR with direct sequencing. Virus:Article Title: Hexameric tetrahedral RNA nanostructures Article Snippet: A Article Title: The intrinsically disordered region of coronins fine-tunes oligomerization and actin polymerization. Article Snippet: REAGENT or Article Title: The β-chain mutation p.Trp433Stop impairs fibrinogen secretion: A novel nonsense mutation associated with hypofibrinogenemia. Article Snippet: Fibrinogen, a hexameric glycoprotein composed of Aα, Bβ, and γ chains, is the most abundant clotting factor in human circulation, and it has a multitude of functions, including platelet aggregation, primary and secondary hemostasis, and fibrinolysis.1 Congenital fibrinogen disorders are divided into two categories: type I, consisting of quantitative defects (afibrinogenemia or hypofibrinogenemia) characterized by absent or low plasma fibrinogen antigen and activity levels, and type II, consisting of qualitative defects Received: 8 December 2020 | Revised: 12 May 2021 | Accepted: 27 May 2021 DOI: 10.1111/ijlh.13632 Article Title: Protocol to identify multiple protein targets and therapeutic compounds using an in silico polypharmacological approach Article Snippet: Article Title: Hexameric tetrahedral RNA nanostructures Article Snippet: A three-dimensional Article Title: Ubiquitin Modification by the E3 Ligase/ADP-ribosyltransferase Dtx3L/Parp9 Article Snippet: Article Title: A novel fibrinogen gamma-chain mutation, p.Cys165Arg, causes disruption of the γ165Cys-Bβ227Cys disulfide bond and ultimately leads to hypofibrinogenemia. Article Snippet: Background: Congenital hypofibrinogenemia is a type of hereditary disease characterized by impaired fibrinogen synthesis and/or secretion induced by mutations in the fibrinogen gene.. Objectives: We investigated the phenotypes, genotypes, and pathogenesis of congenital hypofibrinogenemia in Article Title: Genetic analysis of a pedigree with hereditary coagulation factor XI deficiency Article Snippet: To identify potential mutations of F11 gene in a family with hereditary coagulation factor XI (FXI) deficiency and explore the molecular pathogenesis.. The FXI activity and FXI antigen were tested with clotting assay and ELISA, respectively.. The FXI gene was amplified by PCR with direct sequencing. Plasmid Preparation:Article Title: Hexameric tetrahedral RNA nanostructures Article Snippet: A Article Title: The intrinsically disordered region of coronins fine-tunes oligomerization and actin polymerization. Article Snippet: REAGENT or Article Title: The β-chain mutation p.Trp433Stop impairs fibrinogen secretion: A novel nonsense mutation associated with hypofibrinogenemia. Article Snippet: Fibrinogen, a hexameric glycoprotein composed of Aα, Bβ, and γ chains, is the most abundant clotting factor in human circulation, and it has a multitude of functions, including platelet aggregation, primary and secondary hemostasis, and fibrinolysis.1 Congenital fibrinogen disorders are divided into two categories: type I, consisting of quantitative defects (afibrinogenemia or hypofibrinogenemia) characterized by absent or low plasma fibrinogen antigen and activity levels, and type II, consisting of qualitative defects Received: 8 December 2020 | Revised: 12 May 2021 | Accepted: 27 May 2021 DOI: 10.1111/ijlh.13632 Article Title: Protocol to identify multiple protein targets and therapeutic compounds using an in silico polypharmacological approach Article Snippet: Article Title: Hexameric tetrahedral RNA nanostructures Article Snippet: A three-dimensional Article Title: Ubiquitin Modification by the E3 Ligase/ADP-ribosyltransferase Dtx3L/Parp9 Article Snippet: Article Title: A novel fibrinogen gamma-chain mutation, p.Cys165Arg, causes disruption of the γ165Cys-Bβ227Cys disulfide bond and ultimately leads to hypofibrinogenemia. Article Snippet: Background: Congenital hypofibrinogenemia is a type of hereditary disease characterized by impaired fibrinogen synthesis and/or secretion induced by mutations in the fibrinogen gene.. Objectives: We investigated the phenotypes, genotypes, and pathogenesis of congenital hypofibrinogenemia in Article Title: Genetic analysis of a pedigree with hereditary coagulation factor XI deficiency Article Snippet: To identify potential mutations of F11 gene in a family with hereditary coagulation factor XI (FXI) deficiency and explore the molecular pathogenesis.. The FXI activity and FXI antigen were tested with clotting assay and ELISA, respectively.. The FXI gene was amplified by PCR with direct sequencing. Recombinant:Article Title: Hexameric tetrahedral RNA nanostructures Article Snippet: A Article Title: The intrinsically disordered region of coronins fine-tunes oligomerization and actin polymerization. Article Snippet: REAGENT or Article Title: The β-chain mutation p.Trp433Stop impairs fibrinogen secretion: A novel nonsense mutation associated with hypofibrinogenemia. Article Snippet: Fibrinogen, a hexameric glycoprotein composed of Aα, Bβ, and γ chains, is the most abundant clotting factor in human circulation, and it has a multitude of functions, including platelet aggregation, primary and secondary hemostasis, and fibrinolysis.1 Congenital fibrinogen disorders are divided into two categories: type I, consisting of quantitative defects (afibrinogenemia or hypofibrinogenemia) characterized by absent or low plasma fibrinogen antigen and activity levels, and type II, consisting of qualitative defects Received: 8 December 2020 | Revised: 12 May 2021 | Accepted: 27 May 2021 DOI: 10.1111/ijlh.13632 Article Title: Protocol to identify multiple protein targets and therapeutic compounds using an in silico polypharmacological approach Article Snippet: Article Title: Hexameric tetrahedral RNA nanostructures Article Snippet: A three-dimensional Article Title: Ubiquitin Modification by the E3 Ligase/ADP-ribosyltransferase Dtx3L/Parp9 Article Snippet: Article Title: A novel fibrinogen gamma-chain mutation, p.Cys165Arg, causes disruption of the γ165Cys-Bβ227Cys disulfide bond and ultimately leads to hypofibrinogenemia. Article Snippet: Background: Congenital hypofibrinogenemia is a type of hereditary disease characterized by impaired fibrinogen synthesis and/or secretion induced by mutations in the fibrinogen gene.. Objectives: We investigated the phenotypes, genotypes, and pathogenesis of congenital hypofibrinogenemia in Article Title: Genetic analysis of a pedigree with hereditary coagulation factor XI deficiency Article Snippet: To identify potential mutations of F11 gene in a family with hereditary coagulation factor XI (FXI) deficiency and explore the molecular pathogenesis.. The FXI activity and FXI antigen were tested with clotting assay and ELISA, respectively.. The FXI gene was amplified by PCR with direct sequencing. TNKS1 Histone Ribosylation Assay:Article Title: Hexameric tetrahedral RNA nanostructures Article Snippet: A Article Title: The intrinsically disordered region of coronins fine-tunes oligomerization and actin polymerization. Article Snippet: REAGENT or Article Title: The β-chain mutation p.Trp433Stop impairs fibrinogen secretion: A novel nonsense mutation associated with hypofibrinogenemia. Article Snippet: Fibrinogen, a hexameric glycoprotein composed of Aα, Bβ, and γ chains, is the most abundant clotting factor in human circulation, and it has a multitude of functions, including platelet aggregation, primary and secondary hemostasis, and fibrinolysis.1 Congenital fibrinogen disorders are divided into two categories: type I, consisting of quantitative defects (afibrinogenemia or hypofibrinogenemia) characterized by absent or low plasma fibrinogen antigen and activity levels, and type II, consisting of qualitative defects Received: 8 December 2020 | Revised: 12 May 2021 | Accepted: 27 May 2021 DOI: 10.1111/ijlh.13632 Article Title: Protocol to identify multiple protein targets and therapeutic compounds using an in silico polypharmacological approach Article Snippet: Article Title: Hexameric tetrahedral RNA nanostructures Article Snippet: A three-dimensional Article Title: Ubiquitin Modification by the E3 Ligase/ADP-ribosyltransferase Dtx3L/Parp9 Article Snippet: Article Title: A novel fibrinogen gamma-chain mutation, p.Cys165Arg, causes disruption of the γ165Cys-Bβ227Cys disulfide bond and ultimately leads to hypofibrinogenemia. Article Snippet: Background: Congenital hypofibrinogenemia is a type of hereditary disease characterized by impaired fibrinogen synthesis and/or secretion induced by mutations in the fibrinogen gene.. Objectives: We investigated the phenotypes, genotypes, and pathogenesis of congenital hypofibrinogenemia in Article Title: Genetic analysis of a pedigree with hereditary coagulation factor XI deficiency Article Snippet: To identify potential mutations of F11 gene in a family with hereditary coagulation factor XI (FXI) deficiency and explore the molecular pathogenesis.. The FXI activity and FXI antigen were tested with clotting assay and ELISA, respectively.. The FXI gene was amplified by PCR with direct sequencing. Sequencing:Article Title: Hexameric tetrahedral RNA nanostructures Article Snippet: A Article Title: The intrinsically disordered region of coronins fine-tunes oligomerization and actin polymerization. Article Snippet: REAGENT or Article Title: The β-chain mutation p.Trp433Stop impairs fibrinogen secretion: A novel nonsense mutation associated with hypofibrinogenemia. Article Snippet: Fibrinogen, a hexameric glycoprotein composed of Aα, Bβ, and γ chains, is the most abundant clotting factor in human circulation, and it has a multitude of functions, including platelet aggregation, primary and secondary hemostasis, and fibrinolysis.1 Congenital fibrinogen disorders are divided into two categories: type I, consisting of quantitative defects (afibrinogenemia or hypofibrinogenemia) characterized by absent or low plasma fibrinogen antigen and activity levels, and type II, consisting of qualitative defects Received: 8 December 2020 | Revised: 12 May 2021 | Accepted: 27 May 2021 DOI: 10.1111/ijlh.13632 Article Title: Protocol to identify multiple protein targets and therapeutic compounds using an in silico polypharmacological approach Article Snippet: Article Title: Hexameric tetrahedral RNA nanostructures Article Snippet: A three-dimensional Article Title: Ubiquitin Modification by the E3 Ligase/ADP-ribosyltransferase Dtx3L/Parp9 Article Snippet: Article Title: A novel fibrinogen gamma-chain mutation, p.Cys165Arg, causes disruption of the γ165Cys-Bβ227Cys disulfide bond and ultimately leads to hypofibrinogenemia. Article Snippet: Background: Congenital hypofibrinogenemia is a type of hereditary disease characterized by impaired fibrinogen synthesis and/or secretion induced by mutations in the fibrinogen gene.. Objectives: We investigated the phenotypes, genotypes, and pathogenesis of congenital hypofibrinogenemia in Article Title: Genetic analysis of a pedigree with hereditary coagulation factor XI deficiency Article Snippet: To identify potential mutations of F11 gene in a family with hereditary coagulation factor XI (FXI) deficiency and explore the molecular pathogenesis.. The FXI activity and FXI antigen were tested with clotting assay and ELISA, respectively.. The FXI gene was amplified by PCR with direct sequencing. Control:Article Title: Hexameric tetrahedral RNA nanostructures Article Snippet: A Article Title: The intrinsically disordered region of coronins fine-tunes oligomerization and actin polymerization. Article Snippet: REAGENT or Article Title: The β-chain mutation p.Trp433Stop impairs fibrinogen secretion: A novel nonsense mutation associated with hypofibrinogenemia. Article Snippet: Fibrinogen, a hexameric glycoprotein composed of Aα, Bβ, and γ chains, is the most abundant clotting factor in human circulation, and it has a multitude of functions, including platelet aggregation, primary and secondary hemostasis, and fibrinolysis.1 Congenital fibrinogen disorders are divided into two categories: type I, consisting of quantitative defects (afibrinogenemia or hypofibrinogenemia) characterized by absent or low plasma fibrinogen antigen and activity levels, and type II, consisting of qualitative defects Received: 8 December 2020 | Revised: 12 May 2021 | Accepted: 27 May 2021 DOI: 10.1111/ijlh.13632 Article Title: Protocol to identify multiple protein targets and therapeutic compounds using an in silico polypharmacological approach Article Snippet: Article Title: Hexameric tetrahedral RNA nanostructures Article Snippet: A three-dimensional Article Title: Ubiquitin Modification by the E3 Ligase/ADP-ribosyltransferase Dtx3L/Parp9 Article Snippet: Article Title: A novel fibrinogen gamma-chain mutation, p.Cys165Arg, causes disruption of the γ165Cys-Bβ227Cys disulfide bond and ultimately leads to hypofibrinogenemia. Article Snippet: Background: Congenital hypofibrinogenemia is a type of hereditary disease characterized by impaired fibrinogen synthesis and/or secretion induced by mutations in the fibrinogen gene.. Objectives: We investigated the phenotypes, genotypes, and pathogenesis of congenital hypofibrinogenemia in Article Title: Genetic analysis of a pedigree with hereditary coagulation factor XI deficiency Article Snippet: To identify potential mutations of F11 gene in a family with hereditary coagulation factor XI (FXI) deficiency and explore the molecular pathogenesis.. The FXI activity and FXI antigen were tested with clotting assay and ELISA, respectively.. The FXI gene was amplified by PCR with direct sequencing. Flow Cytometry:Article Title: Hexameric tetrahedral RNA nanostructures Article Snippet: A Article Title: The intrinsically disordered region of coronins fine-tunes oligomerization and actin polymerization. Article Snippet: REAGENT or Article Title: The β-chain mutation p.Trp433Stop impairs fibrinogen secretion: A novel nonsense mutation associated with hypofibrinogenemia. Article Snippet: Fibrinogen, a hexameric glycoprotein composed of Aα, Bβ, and γ chains, is the most abundant clotting factor in human circulation, and it has a multitude of functions, including platelet aggregation, primary and secondary hemostasis, and fibrinolysis.1 Congenital fibrinogen disorders are divided into two categories: type I, consisting of quantitative defects (afibrinogenemia or hypofibrinogenemia) characterized by absent or low plasma fibrinogen antigen and activity levels, and type II, consisting of qualitative defects Received: 8 December 2020 | Revised: 12 May 2021 | Accepted: 27 May 2021 DOI: 10.1111/ijlh.13632 Article Title: Protocol to identify multiple protein targets and therapeutic compounds using an in silico polypharmacological approach Article Snippet: Article Title: Hexameric tetrahedral RNA nanostructures Article Snippet: A three-dimensional Article Title: Ubiquitin Modification by the E3 Ligase/ADP-ribosyltransferase Dtx3L/Parp9 Article Snippet: Article Title: A novel fibrinogen gamma-chain mutation, p.Cys165Arg, causes disruption of the γ165Cys-Bβ227Cys disulfide bond and ultimately leads to hypofibrinogenemia. Article Snippet: Background: Congenital hypofibrinogenemia is a type of hereditary disease characterized by impaired fibrinogen synthesis and/or secretion induced by mutations in the fibrinogen gene.. Objectives: We investigated the phenotypes, genotypes, and pathogenesis of congenital hypofibrinogenemia in Article Title: Genetic analysis of a pedigree with hereditary coagulation factor XI deficiency Article Snippet: To identify potential mutations of F11 gene in a family with hereditary coagulation factor XI (FXI) deficiency and explore the molecular pathogenesis.. The FXI activity and FXI antigen were tested with clotting assay and ELISA, respectively.. The FXI gene was amplified by PCR with direct sequencing. |
